Evommune, Inc.
Calidad de datos: 100%
EVMN
NYSE
Manufacturing
Chemicals
$28.30
▲
$1.17
(4.31%)
Cap. Mercado: 1.02 B
Precio
$28.30
Cap. Mercado
1.02 B
Rango del Día
$27.11 — $28.72
Rango de 52 Semanas
$13.89 — $33.20
Volumen
139,211
Apertura $27.11
Promedio 50D / 200D
$23.81
18.85% above
Promedio 50D / 200D
$21.21
33.42% above
Quick Summary
Puntos Clave
Negative free cash flow of -76.68 M
Capital efficient — spends only 1.81% of revenue on capex
Crecimiento
Revenue Growth (5Y)
N/A
Revenue (1Y)N/A
Earnings (1Y)N/A
FCF Growth (3Y)N/A
Calidad
Return on Equity
-33.50%
Above sector avg (-53.47%)
ROIC-30.93%
Net Margin-529.77%
Op. Margin-623.62%
Seguridad
Debt / Equity
N/A
Current Ratio7.87
Interest CoverageN/A
Valoración
PE (TTM)
-14.80
Below sector avg (-1.47)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | -14.8 | -1.5 |
| P/B | — | 1.6 |
| ROE % | -33.5 | -53.5 |
| Net Margin % | -529.8 | -41.5 |
| Rev Growth 5Y % | — | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | N/A | Revenue Growth (3Y) | N/A |
| Earnings Growth (1Y) | N/A | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | N/A | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 13.00 M | Net Income (TTM) | -68.87 M |
| ROE | -33.50% | ROA | -30.62% |
| Gross Margin | N/A | Operating Margin | -623.62% |
| Net Margin | -529.77% | Free Cash Flow (TTM) | -76.68 M |
| ROIC | -30.93% | FCF Growth (3Y) | N/A |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 7.87 |
| Interest Coverage | N/A | Asset Turnover | 0.06 |
| Working Capital | 71.53 M | Tangible Book Value | -183.14 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -14.80 | Forward P/E | N/A |
| P/B Ratio | N/A | P/S Ratio | 78.41 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | -7.52% | ||
| Market Cap | 1.02 B | Enterprise Value | 992.51 M |
| Per Share | |||
| EPS (Diluted TTM) | -11.22 | Revenue / Share | 0.36 |
| FCF / Share | -2.13 | OCF / Share | -2.12 |
| EPS CAGR (1Y) | N/A | EPS CAGR (5Y) | N/A |
| EPS CAGR (10Y) | N/A | ||
| Efficiency | |||
| CapEx / Revenue | 1.81% | FCF Conversion | 111.33% |
| SBC-Adj. FCF | -82.53 M | Growth Momentum | N/A |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 |
|---|---|
| Revenue | 13.00 M |
| Net Income | -68.87 M |
| EPS (Diluted) | -11.22 |
| Gross Profit | — |
| Operating Income | -81.07 M |
| EBITDA | — |
| R&D Expenses | 74.04 M |
| SG&A Expenses | — |
| D&A | 600,000.0 |
| Interest Expense | — |
| Income Tax | 0.0 |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 |
|---|---|
| Total Assets | 224.95 M |
| Total Liabilities | 19.38 M |
| Shareholders' Equity | 205.57 M |
| Total Debt | — |
| Cash & Equivalents | 44.06 M |
| Current Assets | 153.48 M |
| Current Liabilities | 17.91 M |
{"event":"ticker_viewed","properties":{"ticker":"EVMN","listing_kind":"stock","pathname":"/stocks/evmn","exchange":"NYSE","country":"US"}}